Updates in Small Interfering RNA for the Treatment of Dyslipidemias.

"Declarations Conflict of InterestMR received honoraria from Bruno and AlfaSigma. SC received honoraria from Fidia, Techdow, and Bruno. AC received honoraria from Amgen, AstraZeneca, Daiichi Sankyo, Novartis, Recordati, Servier, and Sanofi. LT received honoraria from Abbott, Amgen, Bayer, Recordati, Sanofi, and Servier. GG and CS have nothing to disclose. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest MR received honoraria from Bruno and AlfaSigma. SC received honoraria from Fidia, Techdow, and Bruno. AC received honoraria from Amgen, AstraZeneca, Daiichi Sankyo, Novartis, Recordati, Servier, and Sanofi. LT received honoraria from Abbott, Amgen, Bayer, Recordati, Sanofi, and Servier. GG and CS have nothing to disclose."

"Funding Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement. This work was partially funded by Banca d’Italia (2023 to MR), by Banca di Credito Cooperativo di Milano (2022 and 2023 to MR), by Italian Ministry of University and Research (grant number 2022ZPS49L to MR and SC), and by Italian Ministry of Health, Ricerca Corrente 2023 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico."